New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Access Is Easy. Choosing the Right ETF Is Not

With 1,790 launches through July 2026, finding an ETF is easy and choosing one is not. 46% of share classes hold under $50 million, and nearly 7 in 10 allocators are reassessing their holdings, with portfolio fit the top criterion. See how 620 professionals select ETFs.

Access the report

›ETF Issuers›WisdomTree›WDNA

WDNA

WisdomTree BioRevolution Fund

Passive ETF Equity ESG Theme: BioTech & Genomics

Not rated

The WDNA Exchange Traded Fund (ETF) is provided by WisdomTree. It is built to track an index: WisdomTree BioRevolution ESG Screened Index. The WDNA ETF provides physical exposure, so by buying it you actually own parts of all the 79 underlying holdings. This share class generates a stream of income by distributing dividends.

$22.31

-$0.91 (-3.92%) 3 days ago

1:30 PM 10/16/26 Closed

1D price range

$22.30$23.29

52W price range

$15.67$24.74

YTD Perf.

+31.84%

YTD Flows

Annualized volatility

Fund AuM

€4M

Share class AuM

€4M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US97717Y6187

TER

0.45%

Inception date

6/3/2021

Issuer

WisdomTree

Benchmark

WisdomTree BioRevolution ESG Screened Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
WDNA WisdomTree BioRevolution UCITS ETF	+2.38%
IBBQ Invesco Nasdaq Biotechnology ETF	-2.44%
DOCG L&G Healthcare Technology & Innovation UCITS ETF	-0.81%
HTEC Robo Global Healthcare Technology and Innovation ETF	+3.58%
BTEE iShares Nasdaq US Biotechnology UCITS ETF	-2.44%
203780 Mirae Asset TIGER NASDAQ BIO ETF	+0.31%
CURE VanEck Genomics and Healthcare Innovators UCITS ETF	-2.53%
00678 CAPITAL NASDAQ BIOTECHNOLOGY INDEX ETF	+4.63%
IBB iShares Biotechnology ETF	-2.08%
TMED T. Rowe Price Health Care ETF	+2.56%
XHE State Street SPDR S&P Health Care Equipment ETF	-0.09%
FMED Fidelity Disruptive Medicine ETF	-3.32%
FBT First Trust NYSE Arca Biotechnology Index Fund ETF	+3.14%
2B78 iShares Healthcare Innovation UCITS ETF	-0.23%
IDNA iShares Genomics Immunology and Healthcare ETF	-3.81%

API

PerformanceDec 31, 2025 - Oct 16, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 08/31/26

Healthcare

90.16%

Non-Energy Materials

6.14%

Consumer Non-Cyclicals

3.58%

Unavailable

0.11%

Latest WDNA news

No content available for this fund

FAQ about WDNA

WDNA is a Passive ETF. This ETF provides exposure to Equally Weighted Developed markets Equities.

WDNA tracks the WisdomTree BioRevolution ESG Screened Net Return Index - USD, through a optimized sampling replication method.

WDNA carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.

WDNA was introduced to the market on June 3, 2021. It trades on United States

WisdomTree BioRevolution Fund, WDNA, is provided by WisdomTree. Learn more about WisdomTree here.

WDNA oversees €4M in assets as of October 16, 2026.

WDNA follows a distributing dividend policy, meaning it pays out income to investors. As of October 16, 2026, its 12-month trailing yield was 3.46%.

As of August 31, 2026, WDNA has significant geographic allocations in USA, United Kingdom and Germany.

As of August 31, 2026, WDNA focuses largely on Healthcare, Non-Energy Materials and Consumer Non-Cyclicals.

As of August 31, 2026, WDNA holds 79 positions in its portfolio, with 44.42% of assets concentrated in its top 15 holdings.

As of August 31, 2026, WDNA top three holdings include Moderna, Inc., Twist Bioscience Corp. and Eli Lilly & Co..

The base currency of WDNA is USD.

Top 10 holdings

Data as of 08/31/26

Moderna, Inc.

7.75%

Twist Bioscience Corp.

7.57%

Eli Lilly & Co.

3.53%

Johnson & Johnson

2.75%

Immunome, Inc.

2.67%

10X Genomics, Inc.

2.65%

Natera, Inc.

2.53%

Tempus AI, Inc.

2.35%

United Therapeutics Corp.

2.05%

Darling Ingredients, Inc.

1.93%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Access Is Easy. Choosing the Right ETF Is Not

WisdomTree BioRevolution Fund

FAQ about WDNA

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US